ClinicalTrials.Veeva

Menu

Identification of Risk Factors for Acute Coronary Events by OCT After STEMI and NSTEMI in Patients With Residual Non-flow Limiting Lesions (PECTUS-obs)

R

Radboud University Medical Center

Status

Active, not recruiting

Conditions

Coronary Artery Disease
Acute Coronary Syndrome
Myocardial Infarction

Treatments

Device: Coronary Optical Coherence tomography

Study type

Interventional

Funder types

Other

Identifiers

NCT03857971
NL67426.091.18

Details and patient eligibility

About

The objective of this study is to compare the clinical outcome of Non-ST-elevation myocardial infarction (NSTEMI) and ST-elevation myocardial infarction (STEMI) patients with non-obstructive, non-culprit coronary lesions and either presence or absence of vulnerable plaque characteristics as assessed by optical coherence tomography (OCT).

Full description

Despite major advances in the treatment of acute coronary syndromes a large proportion of patients is still at risk for new coronary events after experiencing an acute coronary syndrome (ACS). Detection of residual vulnerable plaques after ACS using OCT potentially identifies patients at high risk for new coronary events. However, no prospectively collected data on the prognostic power of OCT for plaque rupture are available at this moment. To design trials aimed to reduce events in patients with vulnerable plaques it is required to collect such prospective data on the relation between OCT derived characteristics of vulnerability and clinical outcome.

Enrollment

438 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Informed consent must be obtained.
  • Patients with STEMI or NSTEMI and residual, non-culprit CAD, with the possibility of plaque vulnerability.
  • Residual plaque(s) is(are) non-obstructive (FFR≥0.80).

Exclusion criteria

  • Refusal or inability to provide informed consent.
  • < 18 years of age
  • Hemodynamic instability, respiratory failure, Kilip class ≥ 3.
  • Previous Coronary Artery Bypass Grafting (CABG).
  • Indication for revascularization by CABG.
  • Anatomy or lesions unsuitable for OCT catheter crossing or imaging (aorta-ostial lesions, small diameter segment, severe calcifications, lesion is too distal for OCT catheter)
  • Pregnancy.
  • Estimated life expectancy < 3 year

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

438 participants in 1 patient group

Coronary OCT imaging of non flow-limiting lesion
Other group
Description:
Coronary OCT imaging will be performed of fractional flow reserve (FFR) negative lesions to assess plaque morphology.
Treatment:
Device: Coronary Optical Coherence tomography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems